These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2677232)

  • 1. C-peptide response to glucagon in young diabetics.
    Juang JH; Huang BY; Huang HS; Lin JD; Huang MJ
    Taiwan Yi Xue Hui Za Zhi; 1989 Jun; 88(6):579-83. PubMed ID: 2677232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum C peptide and IRI levels after administration of glucagon and glucose in non-insulin-dependent diabetics.
    Jayyab AK; Heding LG; Czyzyk A; Malczewski B; Królewski AS
    Horm Metab Res; 1982 Mar; 14(3):112-6. PubMed ID: 7040196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [C-peptide assays of the urine and plasma at baseline and under stimulation with glucagon in healthy subjects and diabetics].
    Sabot O; Tourniaire J; Charrie A; Rebattu B; Jouve M; Ayzac L; Fleury MC
    Presse Med; 1990 May; 19(18):860-3. PubMed ID: 2140181
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
    Li X; Zhou ZG; Qi HY; Chen XY; Huang G
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progressive deterioration of beta-cell function in nonobese type 2 diabetic subjects. Postprandial plasma C-peptide level is an indication of insulin dependency.
    Prando R; Odetti P; Melga P; Giusti R; Ciuchi E; Cheli V
    Diabetes Metab; 1996 Jun; 22(3):185-91. PubMed ID: 8697306
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pancreatic B-cell function in non-insulin-dependent diabetes mellitus during successive periods of sulfonylurea and insulin treatment: serum C-peptide response to glucagon and urine C-peptide excretion.
    Hsieh SD; Iwamoto Y; Matsuda A; Kuzuya T
    Endocrinol Jpn; 1987 Aug; 34(4):561-7. PubMed ID: 3315640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma C-peptide and insulin responses to intravenous glucagon stimulation in idiopathic haemochromatosis.
    Rumbak MJ; Joffe BI; Seftel HC; Kalk WJ; Bezwoda WR; Bothwell TH
    S Afr Med J; 1987 Mar; 71(6):351-3. PubMed ID: 3551126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of porcine gastric inhibitory polypeptide on beta-cell function in type I and type II diabetes mellitus.
    Krarup T; Saurbrey N; Moody AJ; Kühl C; Madsbad S
    Metabolism; 1987 Jul; 36(7):677-82. PubMed ID: 3298936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-peptide response to glucagon. A test for the residual beta-cell function in diabetes mellitus.
    Faber OK; Binder C
    Diabetes; 1977 Jul; 26(7):605-10. PubMed ID: 326604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endocrine pancreatic function in insulin-dependent diabetic pregnant women.
    Fiore R; Maldonato A; Zicari D; Pimpinella G; Gargiulo P; Tinelli FP; Arachi S; Pachi A; Fallucca F
    Acta Endocrinol Suppl (Copenh); 1986; 277():31-6. PubMed ID: 3532667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estimation of B-cell function by the urinary excretion rate of C-peptide in diabetic patients: comparison with C-peptide response to glucagon and to a mixed meal.
    Pasquali R; Buratti P; Biso P; Patrono D; Capelli M; Pasqui F; Melchionda N
    Diabete Metab; 1987 Feb; 13(1):44-51. PubMed ID: 3552774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.
    Gjessing HJ; Matzen LE; Frøland A; Faber OK
    Diabetes Care; 1987; 10(4):487-90. PubMed ID: 3304899
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The diagnostic value of serum C-peptide determination].
    Kober G; Rainer OH
    Acta Med Austriaca; 1983; 10(2-3):67-70. PubMed ID: 6349209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pancreatic alpha-cell function in diabetic hemochromatotic subjects.
    Nelson RL; Baldus WP; Rubenstein AH; Go VL; Service FJ
    J Clin Endocrinol Metab; 1979 Sep; 49(3):412-6. PubMed ID: 381322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. C-peptide response to oral glucose and its clinical role in elderly people.
    Wickramasinghe LS; Chazan BI; Farrow M; Bansal SK; Basu SK
    Age Ageing; 1992 Mar; 21(2):103-8. PubMed ID: 1575087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-peptide response to glucagon in diabetics with and without complications.
    Smith RB; Pyke DA; Watkins PJ; Binder C; Faber OK
    N Z Med J; 1979 Apr; 89(634):304-6. PubMed ID: 377156
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of metformin on blood glucose, insulin and C-peptide responses to glucagon in non-insulin dependent diabetics.
    Ferlito S; Del Campo F; Di Vincenzo S; Damante G; Coco R; Branca S; Fichera C
    Farmaco Sci; 1983 Apr; 38(4):248-54. PubMed ID: 6345193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.
    Juang JH; Huang HS; Huang MJ
    J Formos Med Assoc; 1992 May; 91(5):491-6. PubMed ID: 1358326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early Alterations in Glycemic Control and Pancreatic Endocrine Function in Nondiabetic Patients With Chronic Pancreatitis.
    Lundberg R; Beilman GJ; Dunn TB; Pruett TL; Freeman ML; Ptacek PE; Berry KL; Robertson RP; Moran A; Bellin MD
    Pancreas; 2016 Apr; 45(4):565-71. PubMed ID: 26918872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.